ApoB Blood Test Explained (Australia)
Why ApoB is a better predictor of heart disease than LDL cholesterol, what the Australian reference ranges mean, and how to lower your number — in plain English.
Free to use · No credit card · Works with any Australian lab
The Quick Answer
ApoB (Apolipoprotein B) is a protein that sits on the surface of every artery-damaging lipoprotein in your blood. Crucially, there is exactly one ApoB molecule per particle. So when a lab measures your ApoB level, it is directly counting the total number of atherogenic particles circulating in your bloodstream — something a standard cholesterol panel cannot do.
Research consistently shows that particle count predicts heart attacks and strokes better than LDL cholesterol (the standard LDL-C you see on a routine lipid panel). The biggest reason: LDL-C measures the amount of cholesterol inside LDL particles, not how many particles there are. If you have many small, cholesterol-poor LDL particles, your LDL-C can look normal while your ApoB — and your true heart risk — is elevated.
Which Particles Does ApoB Count?
The clinical ApoB assay measures ApoB-100, the liver-produced form. It captures all the lipoproteins that drive atherosclerosis. HDL is protective and carries ApoA-I, not ApoB, so it is not counted.
LDL (low-density lipoprotein)
The primary target of statins. Each LDL particle carries one ApoB molecule.
VLDL (very-low-density lipoprotein)
Carries triglycerides. Converts to IDL then LDL. Elevated in metabolic syndrome and insulin resistance.
IDL (intermediate-density lipoprotein)
A transition particle between VLDL and LDL. Short-lived but atherogenic.
Lp(a) (lipoprotein(a))
Genetically determined. Contains one ApoB plus an apolipoprotein(a) tail. Independently raises heart risk.
HDL (high-density lipoprotein)
Contains ApoA-I, not ApoB. Reverse cholesterol transport. Higher HDL is generally protective.
Chylomicrons
Carry dietary fat. Contain ApoB-48 (gut isoform), not ApoB-100 (liver isoform). Not counted in clinical ApoB assays.
LDL/ApoB Discordance — The Hidden Risk Pattern
Discordance occurs when your LDL cholesterol and ApoB level tell different stories. The most clinically important pattern is normal LDL-C but elevated ApoB— meaning your routine lipid panel is underestimating your true cardiovascular risk. This is most common in people with insulin resistance, diabetes, or metabolic syndrome.
Metabolic syndrome / insulin resistance
Many small dense LDL particles each carry less cholesterol, keeping LDL-C low while particle count and ApoB are elevated.
High triglycerides (>2 mmol/L)
Hypertriglyceridaemia shifts LDL towards smaller, denser particles. Friedewald LDL calculation also becomes unreliable.
On a statin
Statins reduce both LDL-C and ApoB. ApoB confirms adequate particle reduction beyond what LDL-C alone shows.
Very low fat diet / familial hypocholesterolaemia treatment
Consistent concordance in both directions suggests accurate risk assessment from LDL-C alone.
Type 2 diabetes (poorly controlled)
Hyperinsulinaemia drives overproduction of VLDL and small dense LDL, raising particle count without proportionally raising LDL-C.
Getting an ApoB Test in Australia — Availability and Cost
ApoB is not on the standard Medicare lipid panel (MBS item 66500), which only covers total cholesterol, HDL, LDL (calculated), and triglycerides. However, it is available through essentially all major Australian pathology providers including:
Dorevitch Pathology (Victoria)
Sullivan Nicolaides Pathology (Queensland)
Laverty Pathology (NSW)
Sonic Healthcare / Douglass Hanly Moir (NSW/national)
QML Pathology (Queensland)
SA Pathology (South Australia)
Typical private cost: $30-$50. Some longevity-focused or cardiovascular panels include ApoB as part of a bundle. Ask your GP to add it to your next pathology request — it uses the same blood sample as the standard lipid panel.
Red Flags — When to Act Promptly
ApoB above 1.2 g/L
This level is associated with significantly elevated cardiovascular risk, especially if triglycerides or fasting glucose are also abnormal. Requires formal cardiovascular risk assessment by your GP.
ApoB elevated plus premature family history
A first-degree relative with heart attack or stroke before age 55 (men) or 65 (women) is a major independent risk factor. Combined with high ApoB, this warrants early aggressive management and possible genetic testing for familial hypercholesterolaemia.
Discordance (normal LDL but high ApoB) in a diabetic patient
Type 2 diabetes plus ApoB discordance is one of the highest-risk patterns. Standard lipid targets may be misleading; ApoB-targeted therapy (statins plus ezetimibe) is generally recommended by Australian guidelines.
ApoB not responding to statin therapy
If ApoB remains above target after an adequate dose of statin for 12 weeks, add-on therapy (ezetimibe or PCSK9 inhibitor) should be discussed. Residual elevated particle count on treatment is a strong predictor of future events.
High ApoB plus high Lp(a)
Lp(a) contributes to total ApoB. If both are elevated, the combination is additive for risk. Currently there are no approved therapies specifically for Lp(a) in Australia (aspirin is not effective), but it intensifies the importance of lowering every other modifiable risk factor.
How to Use ApoB in Your Cardiovascular Health Plan
Start with a standard Medicare lipid panel
Total cholesterol, HDL-C, LDL-C, and triglycerides are bulk-billed via Medicare with a valid GP referral. This is the right starting point for most Australians and gives the context needed to interpret ApoB.
Ask your GP to add ApoB (private, ~$30-$50)
Your GP adds ApoB to the same pathology request. It uses the same blood sample as the lipid panel. No fasting is strictly required for ApoB (unlike triglycerides), though fasting is standard practice when getting a lipid panel.
Assess discordance
Compare your LDL-C result with your ApoB. If ApoB is elevated but LDL-C appears normal, you have discordance. This is the highest-value finding from the test. Your GP or cardiologist uses this to recalibrate your cardiovascular risk.
Context: other risk factors matter
ApoB is a risk marker, not a disease. Its significance depends on your age, blood pressure, smoking status, family history, diabetes, and existing heart disease. A high ApoB at 35 in a non-smoking normotensive person is managed differently from the same ApoB at 65 after a heart attack.
Consider Lp(a) if ApoB is borderline and risk is unclear
Lp(a) is counted in ApoB (one Lp(a) particle = one ApoB). If your ApoB is mildly elevated but standard LDL and triglycerides look fine, adding an Lp(a) measurement helps determine how much is driven by this genetically fixed particle versus modifiable lifestyle factors.
Retest after treatment or lifestyle change
After starting a statin, changing diet, or losing significant weight, retest ApoB (and the full lipid panel) after 6-12 weeks. If ApoB drops below 0.8 g/L on primary prevention, most guidelines suggest the intervention is working well.
Track the trend over time
Upload your pathology results to SmarterBlood to plot ApoB alongside your LDL-C, triglycerides, and HDL on a timeline. Seeing the trend makes it much easier to judge whether lifestyle changes or medication are delivering a meaningful reduction.
How to Lower Your ApoB
The same interventions that lower LDL-C also lower ApoB. Below are the key options with approximate expected reductions, ranked by strength of evidence.
Statin therapy
Rosuvastatin and atorvastatin are the most potent. High-intensity statin therapy (e.g. rosuvastatin 20-40 mg or atorvastatin 40-80 mg) achieves the greatest reductions. PBS-subsidised for eligible Australians.
Ezetimibe (add-on)
Inhibits intestinal cholesterol absorption. Additive to statins. PBS-subsidised for patients who cannot tolerate statins or have familial hypercholesterolaemia.
PCSK9 inhibitors
Evolocumab (Repatha) and alirocumab (Praluent) are PBS-subsidised for high-risk patients in Australia. Injected fortnightly or monthly. Highly effective for those with familial hypercholesterolaemia or established cardiovascular disease.
Replacing saturated fat with unsaturated fat
Replacing butter, full-fat dairy, and coconut oil with olive oil, avocado, and oily fish lowers both LDL-C and ApoB through reduced hepatic cholesterol synthesis.
Weight loss (if overweight)
Adipose tissue promotes VLDL overproduction. Losing 5-10% of body weight meaningfully reduces ApoB, particularly in patients with metabolic syndrome.
Reducing refined carbohydrates
High refined carbohydrate intake drives VLDL synthesis and shifts LDL to the small dense subtype. A lower-carbohydrate diet (Mediterranean or LCHF) consistently lowers ApoB in insulin-resistant individuals.
Aerobic exercise
Exercise has a modest direct effect on ApoB but a larger indirect effect by improving insulin sensitivity, which reduces VLDL overproduction. Aim for at least 150 minutes of moderate exercise per week.
Soluble fibre (oats, psyllium, legumes)
Soluble fibre binds bile acids in the gut, forcing the liver to convert more cholesterol to bile acids, which reduces hepatic cholesterol and VLDL output. Two tablespoons of psyllium husks daily has a modest but consistent effect.
ApoB Blood Test - Frequently Asked Questions
What is ApoB and why is it tested?
Apolipoprotein B (ApoB) is a protein found on the surface of every atherogenic (artery-clogging) lipoprotein particle in your blood: LDL, VLDL, IDL and Lp(a). Because there is exactly one ApoB molecule per particle, the ApoB number directly counts how many atherogenic particles are circulating. Research shows that particle count is a better predictor of cardiovascular events than the cholesterol content (LDL-C) measured by a standard lipid panel.
What is a healthy ApoB level in Australia?
Australian labs report ApoB in g/L. For primary prevention (no prior heart attack or stroke), optimal ApoB is below 0.8 g/L. For secondary prevention (known cardiovascular disease or very high risk), many cardiologists target below 0.65 g/L. Borderline high is 0.8-1.0 g/L; high is above 1.0 g/L. These targets are tighter than the standard lab reference range printed on your result.
Is ApoB covered by Medicare in Australia?
ApoB is not on the standard Medicare lipid panel (which covers total cholesterol, HDL, LDL and triglycerides). It is typically a private-pay test, costing around $30-$50 at most Australian pathology labs. Some longevity panels and specialist cardiology assessments include it. A GP can add it to a pathology request and it will be processed by standard labs such as Dorevitch, Sullivan Nicolaides, Laverty, and Sonic Healthcare.
What does LDL/ApoB discordance mean?
LDL/ApoB discordance is when your LDL cholesterol looks normal but your ApoB is elevated. This happens when you have many small, dense LDL particles that carry less cholesterol each but are individually more atherogenic. A standard lipid panel underestimates risk in this situation. Discordance is more common in people with insulin resistance, metabolic syndrome, high triglycerides, or type 2 diabetes.
How can I lower my ApoB?
The same levers that lower LDL cholesterol also lower ApoB: statins (the most potent, typically reducing ApoB by 30-50%), ezetimibe (adds another 15-20%), PCSK9 inhibitors (50-60% reduction, used in high-risk patients), and a diet low in saturated fat. Weight loss in overweight individuals reliably lowers ApoB. Replacing refined carbohydrates with unsaturated fats also helps. Exercise has a modest direct effect but improves insulin sensitivity, which reduces small dense LDL production.
Should I get ApoB instead of a standard lipid panel?
ApoB is a complement to, not a replacement for, the standard lipid panel. Most Australian GPs start with the Medicare-covered lipid panel. ApoB adds the most value when: you have high triglycerides, low HDL, or features of metabolic syndrome (LDL may underestimate risk); your LDL is borderline and you want more information before deciding on a statin; or you are already on a statin and want to verify adequate particle reduction. Discuss with your GP whether adding ApoB is worthwhile for your situation.
How often should ApoB be measured?
For most healthy adults, measuring ApoB every 2-5 years alongside a standard lipid panel is reasonable. If you have started a new lipid-lowering medication or made significant lifestyle changes, rechecking after 6-12 weeks confirms the response. People with confirmed cardiovascular disease or very high risk may be monitored more frequently by their cardiologist. Tracking the trend over time is often more useful than any single reading.
Related Reading
Know Your ApoB. Track It Over Time.
Upload your blood test PDF and SmarterBlood's AI will explain every marker in plain English — including ApoB, LDL-C, HDL, and triglycerides — and plot them on a timeline so you can see at a glance whether your interventions are working.
This page provides general educational information about the ApoB blood test and cardiovascular risk markers. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss abnormal lipid results with your GP or cardiologist — cardiovascular risk assessment requires consideration of your full medical history, not just a single marker. SmarterBlood does not provide medical care.